Immunization, Pol3 in Europe & Central Asia
Europe & Central Asia: Immunization, Pol3 was 93.0% in 2024. ▲ Rising
Immunization, Pol3 in Europe & Central Asia, 1992–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of one-year-old children.
Analysis
The most recent figure for immunization, pol3 in Europe & Central Asia is 93.0%, measured in 2024.
That represents a change of down 1.3% on the previous year and down 0.1% over ten years.
Over the whole period, immunization, pol3 in Europe & Central Asia peaked at 95.8% in 2007 and was at its lowest, 84.3%, in 1992.
Europe & Central Asia ranks 7th of 43 groups on this measure, in the top quarter.
The long-run direction has been consistently rising across the 33 years of available data.
Immunization, Pol3 in Europe & Central Asia, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1992 | 84.3% | — |
| 1993 | 84.5% | +0.2% |
| 1994 | 88.2% | +4.3% |
| 1995 | 88.6% | +0.5% |
| 1996 | 91.1% | +2.8% |
| 1997 | 92.5% | +1.5% |
| 1998 | 92.9% | +0.4% |
| 1999 | 93.3% | +0.4% |
| 2000 | 94.0% | +0.8% |
| 2001 | 94.5% | +0.6% |
| 2002 | 93.4% | -1.1% |
| 2003 | 91.4% | -2.2% |
| 2004 | 94.7% | +3.6% |
| 2005 | 95.0% | +0.3% |
| 2006 | 95.0% | +0.0% |
| 2007 | 95.8% | +0.9% |
| 2008 | 95.8% | -0.1% |
| 2009 | 95.2% | -0.7% |
| 2010 | 94.5% | -0.7% |
| 2011 | 94.4% | -0.1% |
| 2012 | 95.4% | +1.1% |
| 2013 | 94.7% | -0.8% |
| 2014 | 93.1% | -1.7% |
| 2015 | 93.7% | +0.7% |
| 2016 | 93.4% | -0.4% |
| 2017 | 93.0% | -0.4% |
| 2018 | 94.0% | +1.1% |
| 2019 | 94.6% | +0.6% |
| 2020 | 93.7% | -0.9% |
| 2021 | 93.5% | -0.2% |
| 2022 | 93.7% | +0.2% |
| 2023 | 94.1% | +0.4% |
| 2024 | 93.0% | -1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 89.4% | 84.3% | 93.3% | 8 |
| 2000s | 94.5% | 91.4% | 95.8% | 10 |
| 2010s | 94.1% | 93.0% | 95.4% | 10 |
| 2020s | 93.6% | 93.0% | 94.1% | 5 |
More health data for Europe & Central Asia
- Population ages 35-39, female, annual growth rate -0.1309 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 0.2923 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0361 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 0.1122 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0355 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, per capita 0.0301 units per person (2025)
Frequently asked questions
- What is immunization, pol3 in Europe & Central Asia?
- Immunization, pol3 in Europe & Central Asia was 93.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, pol3 recorded in Europe & Central Asia?
- The highest recorded value was 95.8% in 2007.
- What is the lowest immunization, pol3 recorded in Europe & Central Asia?
- The lowest recorded value was 84.3% in 1992.
- How does Europe & Central Asia rank for immunization, pol3?
- Europe & Central Asia ranks 7th out of 43 groups with data for 2024.
- Is immunization, pol3 rising or falling in Europe & Central Asia?
- Over the last ten years it is down 0.1%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Pol3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, polio, is the percentage of children ages 12-23 months who received polio vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.